Aileron Therapeutics to Present at May 2024 Investor Conferences

28 June 2024

May 06, 2024 – Aileron Therapeutics, Inc. (NASDAQ: ALRN), a biopharmaceutical company committed to developing groundbreaking treatments for rare pulmonary and fibrotic diseases, has announced upcoming presentations by its President and CEO, Brian Windsor, Ph.D., at two key investor conferences.

The first conference, the Citizens JMP Life Sciences Conference, will take place on Monday, May 13, 2024. Dr. Windsor is scheduled to present at 12:00 p.m. EDT. The format for this presentation will be a company overview, where Dr. Windsor will discuss the latest advancements and strategic initiatives of Aileron Therapeutics.

The second event, the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ, is scheduled for Monday, May 20, 2024, at 5:00 p.m. EDT. This session will take the form of a fireside chat, providing an interactive platform for Dr. Windsor to engage in detailed discussions about the company's progress and future plans.

Both presentations will be accessible via live webcast, with replays available for 90 days following the live events.

Aileron Therapeutics is dedicated to pioneering innovative therapies for diseases with significant unmet medical needs, particularly in the areas of orphan pulmonary and fibrosis indications. The company’s leading candidate, LTI-03, is a synthetic peptide designed to support alveolar epithelial cell survival and inhibit profibrotic signaling. LTI-03 is currently undergoing a Phase 1b clinical trial aimed at treating idiopathic pulmonary fibrosis, with results from Cohort 2 expected in the third quarter of this year.

Another promising candidate from Aileron’s pipeline is LTI-01, a proenzyme developed for the treatment of loculated pleural effusions. LTI-01 has progressed through Phase 1b and Phase 2a clinical trials and has been awarded Orphan Drug Designation in both the United States and the European Union, as well as Fast Track Designation in the United States.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!